+45 50 20 60 71 
+1 209 213 2250
An Overview of Alzheimer’s Disease
Introduction Alzheimer’s disease is a serious medical condition that affects millions of people worldwide. It is the most common form […]
OptoCeutics is Presenting at The 15th Clinical Trial on Alzheimer’s Disease (CTAD 2022)
[vc_row][vc_column][vc_column_text]Copenhagen, Denmark, 24 November 2022 – OptoCeutics ApS (”OptoCeutics” or ”The Company”) is pleased to inform that they will be […]
OptoCeutics Launches ALZLIGHT Stage III Clinical Trial
[vc_row][vc_column][vc_column_text] Study on the Effect of 40 Hz Non-Invasive Light Therapy System [/vc_column_text][vc_column_text] The ALZLIGHT STAGE III Study is a […]
Natural Brainwaves: A Novel Therapeutic Target to Restore Brain Health
[vc_row thb_full_width=”true” css=”.vc_custom_1626870929996{padding-top: 3vh !important;padding-right: 3vh !important;padding-bottom: 3vh !important;padding-left: 3vh !important;}”][vc_column][vc_column_text] ❚ Brain Waves Brain waves are electrical impulses in […]
An Overview of Alzheimer’s Disease
Introduction Alzheimer’s disease is a serious medical condition that affects millions of people worldwide. It is the most common form […]
OptoCeutics is Presenting at The 15th Clinical Trial on Alzheimer’s Disease (CTAD 2022)
[vc_row][vc_column][vc_column_text]Copenhagen, Denmark, 24 November 2022 – OptoCeutics ApS (”OptoCeutics” or ”The Company”) is pleased to inform that they will be […]
OptoCeutics Launches ALZLIGHT Stage III Clinical Trial
[vc_row][vc_column][vc_column_text] Study on the Effect of 40 Hz Non-Invasive Light Therapy System [/vc_column_text][vc_column_text] The ALZLIGHT STAGE III Study is a […]
Natural Brainwaves: A Novel Therapeutic Target to Restore Brain Health
[vc_row thb_full_width=”true” css=”.vc_custom_1626870929996{padding-top: 3vh !important;padding-right: 3vh !important;padding-bottom: 3vh !important;padding-left: 3vh !important;}”][vc_column][vc_column_text] ❚ Brain Waves Brain waves are electrical impulses in […]
An Overview of Alzheimer’s Disease
Introduction Alzheimer’s disease is a serious medical condition that affects millions of people worldwide. It is the most common form […]
OptoCeutics is Presenting at The 15th Clinical Trial on Alzheimer’s Disease (CTAD 2022)
[vc_row][vc_column][vc_column_text]Copenhagen, Denmark, 24 November 2022 – OptoCeutics ApS (”OptoCeutics” or ”The Company”) is pleased to inform that they will be […]
OptoCeutics Launches ALZLIGHT Stage III Clinical Trial
[vc_row][vc_column][vc_column_text] Study on the Effect of 40 Hz Non-Invasive Light Therapy System [/vc_column_text][vc_column_text] The ALZLIGHT STAGE III Study is a […]
Natural Brainwaves: A Novel Therapeutic Target to Restore Brain Health
[vc_row thb_full_width=”true” css=”.vc_custom_1626870929996{padding-top: 3vh !important;padding-right: 3vh !important;padding-bottom: 3vh !important;padding-left: 3vh !important;}”][vc_column][vc_column_text] ❚ Brain Waves Brain waves are electrical impulses in […]
ARTICLE
An Overview of Alzheimer’s Disease
Introduction Alzheimer’s disease is a serious medical condition that affects millions of people worldwide. It is the most common form of...
NEWS
OptoCeutics is Presenting at The 15th Clinical Trial on Alzheimer’s Disease (CTAD 2022)
[vc_row][vc_column][vc_column_text]Copenhagen, Denmark, 24 November 2022 – OptoCeutics ApS (”OptoCeutics” or ”The Company”) is pleased to inform that they will be presenting...
NEWS
OptoCeutics Launches ALZLIGHT Stage III Clinical Trial
[vc_row][vc_column][vc_column_text] Study on the Effect of 40 Hz Non-Invasive Light Therapy System [/vc_column_text][vc_column_text] The ALZLIGHT STAGE III Study is a continuation...
ARTICLE
Natural Brainwaves: A Novel Therapeutic Target to Restore Brain Health
[vc_row thb_full_width=”true” css=”.vc_custom_1626870929996{padding-top: 3vh !important;padding-right: 3vh !important;padding-bottom: 3vh !important;padding-left: 3vh !important;}”][vc_column][vc_column_text] ❚ Brain Waves Brain waves are electrical impulses in the...
